SJG-136 Uses, Dosage, Side Effects and more
SJG-136 has been used in trials studying the treatment of Recurrent Fallopian Tube Cancer, Secondary Acute Myeloid Leukemia, de Novo Myelodysplastic Syndromes, Recurrent Ovarian Epithelial Cancer, and Secondary Myelodysplastic Syndromes, among others.
| Attribute | Details |
|---|---|
| Trade Name | SJG-136 |
| Generic | SJG-136 |
| Type | |
| Formula | C31H32N4O6 |
| Weight | Average: 556.619 Monoisotopic: 556.232184766 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
